UBS Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $14

Futu News03:32 · Ratings

A Quick Look at Today's Ratings for Avadel Pharmaceuticals(AVDL.US), With a Forecast Between $13 to $22

Futu NewsJan 11 21:00 · Ratings

Avadel Pharmaceuticals Is Maintained at Overweight by Piper Sandler

Dow JonesJan 11 01:46 · Ratings

Avadel Pharmaceuticals Down Nearly 31%, on Pace for Largest Percent Decrease Since May 2022 -- Data Talk

Dow JonesJan 11 00:25

Top Premarket Decliners

MT NewswiresJan 10 20:56

Piper Sandler Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $13

Futu NewsJan 10 20:31 · Ratings